Joseph M. Patti founded Inhibitex LLC. Presently, he is President, Chief Executive Officer & Director at Agilvax, Inc. and President of JP Biotech Advisors, Inc.
He is also on the board of Armata Pharmaceuticals, Inc. and ECM Biosurgery, Inc.
In the past Joseph M. Patti occupied the position of President & Chief Executive Officer for Vaxart, Inc. and President, CEO & Executive Director at Aviragen Therapeutics, Inc. (a subsidiary of Vaxart, Inc.), Senior Vice President-Research & Development at Inhibitex LLC, Assistant Professor at Texas A&M University and Assistant Professor at Institute of Biosciences & Technology.
Dr. Patti received an undergraduate degree from the University of Pittsburgh, a graduate degree from The University of Miami Leonard M. Miller School of Medicine and a doctorate from The University of Alabama at Birmingham.